Finance

Lists
603858:SHA
Shandong Buchang Pharmaceuticals Co Ltd
CNÂ¥14.81
-0.27%
(-0.040) 1D
Sep 7, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603858...
Open
CNÂ¥14.91
High
CNÂ¥14.95
Low
CNÂ¥14.79
Mkt. cap
15.66B
Avg. vol.
6.85M
Volume
3.29M
Dividend
3.85%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
Aug 6, 2026
P/E ratio
66.45
52-wk high
CNÂ¥19.66
52-wk low
CNÂ¥14.01
EPS
CNÂ¥0.22
Shares outstanding
886.34M
No. of employees
7K
Open
CNÂ¥14.91
High
CNÂ¥14.95
Low
CNÂ¥14.79
Mkt. cap
15.66B
Avg. vol.
6.85M
Volume
3.29M
Dividend
3.85%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
Aug 6, 2026
P/E ratio
66.45
52-wk high
CNÂ¥19.66
52-wk low
CNÂ¥14.01
EPS
CNÂ¥0.22
Shares outstanding
886.34M
No. of employees
7K
About Shandong Buchang Pharmaceuticals Co Ltd
CEO-
Employees7.24K
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.80B
3.41B
2.58B
2.42B
Cost of goods sold
1.06B
1.49B
945.27M
996.61M
Cost of revenue
1.06B
1.49B
945.27M
996.61M
Research and development expenses
69.43M
86.47M
42.83M
64.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.34B
1.70B
1.13B
1.06B
Operating expense
1.41B
1.87B
1.20B
1.14B
Total operating expenses
2.47B
3.36B
2.15B
2.14B
Operating income
334.65M
50.77M
433.07M
288.83M
Other non operating income
-4.01M
278.34K
43.04K
-67.75M
EBT including unusual items
270.99M
-486.62M
382.58M
220.29M
EBT excluding unusual items
303.69M
18.26M
405.18M
249.02M
Income tax expense
70.09M
112.21M
79.48M
61.57M
Effective tax rate
25.86%
-23.06%
20.77%
27.95%
Other operating expenses
-2.40M
66.68M
24.57M
22.53M
Net income
240.62M
-507.54M
320.41M
182.17M
Net profit margin
8.58%
-14.90%
12.42%
7.52%
Earnings per share
-
-
-
-
Interest and investment income
1.81M
-
786.69K
28.72M
Interest expense
-28.72M
-34.81M
-28.72M
-786.69K
Net interest expenses
-26.90M
-34.81M
-27.94M
27.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
443.32M
161.53M
543.83M
409.71M
Gain or loss from assets sale
157.22K
-156.48K
-
-109.72K
AI content may include mistakes. Learn more
Google apps